Effect of weight training and whey protein on gene expression Atrial natriuretic peptide(ANP), Brain natriuretic peptide (BNP) and galactin 3

Effect of a weight training period and whey protein on gene expression Atrial natriuretic peptide(ANP), Brain natriuretic peptide (BNP) and galactin 3 inactive men 60-65 years old

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171210037809N7

Enrollment

129

Registered

2020-12-09

Start date

2020-12-08

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

We have no disease / The effect of his protein is considered with exercise.

Interventions

Intervention 1: training group: Exercise is a 6-week exercise protocol (3 sessions per week) with an intensity of 60 to 70% of a variable maximum repetition will perform by exercise groups. Intervent

Eligibility

Sex/Gender

Male

Age

60 Years to 65 Years

Inclusion criteria

Inclusion criteria: Over the past six months, they have not consumed any supplements or medications It does not exclude any history of common chronic health problems and diseases, such as respiratory, metabolic, cardiovascular, renal and hepatic diseases

Exclusion criteria

Exclusion criteria: Over the past six months, they have not consumed any supplements or medications It does not exclude any history of common chronic health problems and diseases, such as respiratory, metabolic, cardiovascular, renal and hepatic diseases

Design outcomes

Primary

Measure	Time frame
Atrial natriuretic peptide(ANP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide (ANP): pg /ml.;Brain natriuretic peptide(BNP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide(BNP) : pg /ml.;Galectin3. Timepoint: At the beginning of the study (before the intervention) and after 6 weeks. Method of measurement: Blood collection :changes Galectin 3 : pmo /ml.	—

Measure

Time frame

Atrial natriuretic peptide(ANP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide (ANP): pg /ml.;Brain natriuretic peptide(BNP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide(BNP) : pg /ml.;Galectin3. Timepoint: At the beginning of the study (before the intervention) and after 6 weeks. Method of measurement: Blood collection :changes Galectin 3 : pmo /ml.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSiavash Shahdusti

Islamic Azad University

info@iauvaramin.ac.ir+98 21 3672 5011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026